Physician profile
Elizabeth Nace
NPI 1720561855
$1,344.12
in general payments reported to CMS, 2019-2025
12 companies · $578 in 2025
The $578 reported for 2025 was more than what 83% of Pediatrics (Optometrist) providers received nationally (typical 2025 total: $152).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $105 · 2020: $17.24 · 2021: $36.64 · 2022: $306 · 2023: $202 · 2024: $99.92 · 2025: $578.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $746 · Entertainment: $134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $746.05 |
| Entertainment | $133.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $363.19 | 2022-2025 | Myday Contact Lens, Misight Contact Lens |
| Alcon Vision LLC | $233.30 | 2022-2023 | Clareon |
| Glaukos Corporation | $209.06 | 2025 | Kxl System (Not Refurbished) |
| Optos, INC. | $133.93 | 2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Bausch & Lomb Americas INC. | $119.40 | 2022-2025 | Xiidra, Miebo |
| Novartis Pharmaceuticals Corporation | $104.64 | 2019 | |
| Visioneering Technologies, INC. | $69.38 | 2022-2024 | |
| Johnson & Johnson Vision Care, INC. | $37.92 | 2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $20.99 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $19.42 | 2025 | Xdemvy |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Dexcom, INC. | $15.65 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Nace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.